Topic
Multiple Sclerosis
Why and when do individuals with multiple sclerosis want to stop their therapy?
Setup
Design
R
Realized in R-Statistics, SQL
Real-world Persistence on a Multiple Sclerosis Treatment (Ozanimod)
Using real-world data, we investigated the persistence of patients diagnosed with relapsing remitting multiple sclerosis on the treatment ozanimod.
Using retrospective real-world data from the NeuroTransData registry, we described the characteristics of and modeled the time to discontinuation of the comparably new treatment ozanimod, compared to the status-quo treatments dimethyl fumarate and teriflunomide. To this end, we used time-to-event methods and Cox regressions.
